Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice

Peptides

Volumn 24, Issue 1, 2003, Pages 99-106

  Lee, Edward W ^a   Grant, Derrick S ^b   Movafagh, Sharareh ^a   Zukowska, Zofia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Angiogenesis; Neuropeptide Y; Y2 receptor; Y2KO mice

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; RECEPTOR BLOCKING AGENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CONTROLLED STUDY; EMBRYO; GASTROCNEMIUS MUSCLE; GEL; KNOCKOUT MOUSE; MALE; MOUSE; MUSCLE ISCHEMIA; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; REVASCULARIZATION; SPROUTING; VASCULAR RING; WILD TYPE;

EID: 0037255766     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00281-4     Document Type: Article

References (50)

1. Baffour R., Berman J., Garb J.L., Rhee S.W., Kaufman J., Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. 16:1992;181-191.
2. Blomquist A.G., Herzog H. Y-receptor subtypes - how many more? Trends Neurosci. 20:1997;294-298.
3. Breier G., Damert A., Plate K.H., Risau W. Angiogenesis in embryos and ischemic diseases. Thromb. Haemost. 78:1997;678-683.
4. Burkhoff A., Linemeyer D.L., Salon J.A. Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat. Brain Res. Mol. Brain Res. 53:1998;311-316.
5. Carmeliet P., Collen D. Molecular analysis of blood vessel formation and disease. Am. J. Physiol. 273:1997;H2091-H2104.
6. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M.et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7:2001;575-583.
7. Chawla P.S., Keelan M.H., Kipshidze N. Angiogenesis for the treatment of vascular diseases [editorial]. Int. Angiol. 18:1999;185-192.
8. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F.et al. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol. 384:1999;R3-R5.
9. Duhault J., Boulanger M., Chamorro S., Boutin J.A., Della Zuana O., Douillet E.et al. Food intake regulation in rodents: Y5 or Y1 NPY receptors or both? Can. J. Physiol. Pharmacol. 78:2000;173-185.
10. Dumont Y., Jacques D., Bouchard P., Quirion R. Species differences in the expression and distribution of the neuropeptide Y, Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J. Comp. Neurol. 402:1998;372-384.
11. Furtinger S., Pirker S., Czech T., Baumgartner C., Ransmayr G., Sperk G. Plasticity of y1 and y2 receptors and neuropeptide y fibers in patients with temporal lobe epilepsy. J. Neurosci. 21:2001;5804-5812.
12. Grant D.S., Kinsella J.L., Fridman R., Auerbach R., Piasecki B.A., Yamada Y.et al. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J. Cell. Physiol. 153:1992;614-625.
13. Grouzmann E., Buclin T., Martire M., Cannizzaro C., Dorner B., Razaname A.et al. Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist. J. Biol. Chem. 272:1997;7699-7706.
14. Grundemar L, Bloom SR. Neuropeptide Y and drug development. San Diego, London: Academic Press, 1997.
15. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA. 89:1992;5794-5798.
16. Kerbel R.S. Tumor angiogenesis: past, present and the near future. Carcinogenesis. 21:2000;505-515.
17. Kibbey M.C., Grant D.S., Kleinman H.K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J. Natl. Cancer Inst. 84:1992;1633-1638.
18. Kitlinska J., Lee E.W., Movafagh S., Pons J., Zukowska Z. Neuropeptide Y-induced angiogenesis in aging. Peptides. 23:2002;71-77.
19. Kitlinska J, Movafagh S, Zukowska Z. Neuropeptide Y - the role in tumor growth and angiogenesis. In: Days of molecular medicine. San Diego, CA, 2002.
20. Lee EW, Dayao E, Ji H, Zukowska Z. Neuropeptide Y-mediated Angiogenesis in vivo. SEBM Research Forum, Washington, DC. P Soc Exp Biol Med; 2000. p. 233.
21. Lee EW, Grant DS, Kitlinska J, Ji H, Yoo P, Kalezic I, et al. Neuropeptide Y: a new neurogenic mechanism for ischemic angiogenesis. In: Days of molecular medicine. San Diego, CA, 2002.
22. Lever A.F. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J. Hypertens. 4:1986;515-524.
23. Li L, Bojakowski K, Kitlinska J, Lee EW, Zukowska Z. Differential effect of neuropeptide Y (NPY) on neointimal formation due to angioplasty and transplantation. Circulation: American Heart Association; 2001. p. 318.
24. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnick M.A.et al. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. 270:1995;29123-29128.
25. Malmstrom R.E., Alexandersson A., Balmer K.C., Weilitz J. In vivo characterization of the novel neuropeptide Y Y1 receptor antagonist H 409/22. J. Cardiovasc. Pharmacol. 36:2000;516-525.
26. Marti H.H., Risau W. Angiogenesis in ischemic disease. Thromb. Haemost. 82(Suppl. 1):1999;44-52.
27. Kim J., Karwatowska-Prokopezuk E., Ji H., Movafagh S., Wesley L., Zukowska-Grojec Z. Multiple receptors and protease activity determine neuropeptide Y (NPY) growth factor and chemotactic actions. Circulation. 96(Suppl. I):1997;1-354.
28. Naveilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk A., Chhajlani V.et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat. Med. 5:1999;1188-1193.
29. Nicosia R.F., Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab. Invest. 63:1990;115-122.
30. Oberto A., Panzica G., Altruda F., Eva C. Chronic modulation of the GABA(A) receptor complex regulates Y1 receptor gene expression in the medial amygdala of transgenic mice. Neuropharmacology. 39:2000;227-234.
31. Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z. Neuropeptide Y and vascular growth: role of Y1 and Y5 receptors and adrenergic activation. Can J Phys Pharm, in press.
32. Potter E.K. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neurosci. Lett. 54:1985;117-121.
33. Potter E.K., Barden J.A., McCloskey M.J., Selbie L.A., Tseng A., Herzog H.et al. A novel neuropeptide Y analog, N-acetyl [Leu28, Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor. Eur. J. Pharmacol. 267:1994;253-262.
34. Reibel S., Nadi S., Benmaamar R., Larmet Y., Carnahan J., Marescaux C.et al. Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation. Peptides. 22:2001;529-539.
35. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
36. Rose P.M., Fernandes P., Lynch J.S., Frazier S.T., Fisher S.M., Kodukula K.et al. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor [published erratum appears in J Biol Chem 1995 Dec 1;270(48):29038]. J. Biol. Chem. 270:1995;22661-22664.
37. Rueeger H., Rigollier P., Yamaguchi Y., Schmidlin T., Schilling W., Criscione L.et al. Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists. Bioorg. Med. Chem. Lett. 10:2000;1175-1179.
38. Stavri G.T., Zachary I.C., Baskerville P.A., Martin J.F., Erusalimsky J.D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation. 92:1995;11-14.
39. Wahlestedt C., Regunathan S., Reis D. Identification of cultured cells selectively expressing Y1-, Y2- and Y3 types of receptors for neuropeptide Y/peptide YY. Life Sci. 50:1992;L7-L12.
40. Wakui S., Furusato M., Ohshige H., Ushigome S. Endothelial-pericyte interdigitations in rat subcutaneous disc implanted angiogenesis. Microvasc. Res. 46:1993;19-27.
41. Ware J.A., Simons M. Angiogenesis in ischemic heart disease. Nat. Med. 3:1997;158-164.
42. Weinberg D.H., Sirinathsinghji D.J., Tan C.P., Shiao L.L., Morin N., Rigby M.R.et al. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 271:1996;16435-16438.
43. Yamagishi S., Kawakami T., Fujimori H., Yonekura H., Tanaka N., Yamamoto Y.et al. Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvasc. Res. 57:1999;329-339.
44. Yang H.T., Deschenes M.R., Ogilvie R.W., Terjung R.L. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79:1996;62-69.
45. You J., Edvinsson L., Bryan R.M. Jr. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries. J. Cereb. Blood Flow Metab. 21:2001;77-84.
46. Yu J., Moon A., Kim H.R. Both platelet-derived growth factor receptor (PDGFR)-alpha and PDGFR-beta promote murine fibroblast cell migration. Biochem. Biophys. Res. Commun. 282:2001;697-700.
47. Zukowska-Grojec Z. Neuropeptide Y: implications in vascular remodeling and novel therapeutics. Drug News Perspectives. 10:1997;587-595.
48. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Fisher T.A., Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul. Pept. 75-76:1998;231-238.
49. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H.et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83:1998;187-195.
50. Zukowska-Grojec Z., Pruszczyk P., Colton C., Yao J., Shen G.H., Myers A.K.et al. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 14:1993;263-268.